Peer-reviewed veterinary case report
Strong immune protection in dogs vaccinated against Leishmania
By Bourdoiseau, G et al.·Published in Veterinary immunology and immunopathology·2009·Laboratoire de Parasitologie, France·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs.
- Species:
- dog
Plain-English summary
A group of dogs vaccinated with a new Leishmania vaccine showed strong immune responses that helped protect them from the disease, while unvaccinated dogs did not have this protection. Two and eight months after vaccination, the vaccinated dogs had a significant ability to fight off the Leishmania parasite, which causes serious health issues. The study found that both types of immune responses—cell-mediated and antibody-based—worked together to provide better protection against the infection. This suggests that the vaccine could be an effective way to help dogs avoid Leishmania-related health problems.
People also search for: dog Leishmania vaccine · dog immune response to Leishmania · how to protect dogs from Leishmania
Abstract
Cell-mediated and humoral immunity were explored in LiESAp-MDP vaccinated protected dogs versus susceptible placebo dogs 2 months and 8 months post-vaccination. As previously described, a strong and long-lasting cell-mediated immunity, critical for protection against Leishmania infantum was exclusively revealed in vaccinated dogs as confirmed by a positive response to the intradermal inoculation of leishmanin and by a significant higher anti-leishmanial activity of canine monocytes-derived macrophages. Moreover, our results support the view that cooperation of humoral antibody with cell-mediated immunity might be important in developing protective immunity in LiESAp-MDP vaccinated dogs. Anti-LiESAp serum samples were found functionally active in vitro, promoting (i) early killing of pretreated promastigotes and amastigotes, (ii) strong inhibitory effect on the in vitro growth of both parasitic developmental stages of L. infantum and (iii) most importantly, a significant inhibition of pretreated promastigotes in vitro infectivity in canine macrophages. However, anti-LiESAp antibody response was not implicated in the promastigotes-amastigotes differentiation process. In these experiments, we have added additional support to the concept that antibodies to Leishmania may be important in developing protective immunity.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/19046774/